| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (penicillin-susceptible) |
- |
- |
0.2 － 0.78 |
Cefamandole (Mandol)  |
1410 |
| Staphylococcus aureus (penicillin-susceptible) |
- |
- |
0.2 － ? |
Cephalothin (Cefalotin, Keflin, Seffin) |
1410 |
| Staphylococcus aureus (penicillin-susceptible) |
- |
- |
0.2 － ? |
Cephapirin |
1410 |
| Staphylococcus aureus (penicillin-susceptible) |
- |
- |
0.78 － 3.12 |
Cephalexin (Keflex, Keftal, Cefanox) |
1410 |
| Staphylococcus aureus (penicillin-susceptible) |
- |
- |
0.78 － 12.5 |
BL-S786 (Ceforanide) |
1410 |
| Staphylococcus aureus (penicillin-susceptible) |
- |
- |
0.78 － 12.5 |
Cefoxitin (Mefoxin) |
1410 |
| Staphylococcus aureus (plus serum) |
- |
- |
2 － ? |
Platensimycin |
517 |
| Staphylococcus aureus (plus serum) |
- |
- |
2 － ? |
Platensimycin |
106 |
| Staphylococcus aureus (plus serum) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
106 |
| Staphylococcus aureus (plus serum) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
517 |
| Staphylococcus aureus (plus serum) |
- |
- |
8 － ? |
Platencin |
517 |
| Staphylococcus aureus (plus serum) |
- |
- |
8 － ? |
Platencin |
106 |
| Staphylococcus aureus (polymyxin B-resistant) |
- |
- |
≥4 － ? |
Polymyxin B (Aerospin) |
452 |
| Staphylococcus aureus (polymyxin B-susceptible) |
- |
- |
≤2 － ? |
Polymyxin B (Aerospin) |
452 |
| Staphylococcus aureus (POMM 6214 + methicillin-resistant) |
- |
- |
1 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
451 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
0.1 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
0.5 － ? |
Tigecycline (GAR-936, Tigacyl) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
1 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
1 － ? |
Quinupristin/Dalfopristin (Synercid) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
2 － ? |
Daptomycin (Cubicin) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
4 － ? |
Teicoplanin (Targocid) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
8 － ? |
Gentamicin (Gentamycin, Garamycin) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
16 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
901 |
| Staphylococcus aureus (pork isolate + Korea) |
- |
- |
>128 － ? |
Mupirocin (Bactroban) |
901 |
| Staphylococcus aureus (preclinical isolate + methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 32 |
Rifampicin (Rifampin) |
477 |
| Staphylococcus aureus (preclinical isolate + methicillin-resistant) |
0.5 |
1 |
≤0.06 － 16 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Staphylococcus aureus (preclinical isolate + methicillin-resistant) |
1 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
477 |